Embecta ( NASDAQ:EMBC – Get Rating ) is one of 224 public companies in the 'Surgical & medical instruments' industry, but how does it compare to its rivals? We will compare Embecta to similar businesses based on the strength of its analyst recommendations, profitability, risk, institutional ownership, earnings, dividends and valuation. Earnings and Valuation This table compares Embecta and its rivals gross revenue, earnings per share and valuation. Gross Revenue Net Income Price/Earnings Ratio Embecta $1.

https://www.dailypolitical.com/2023/06/12/embecta-embc-vs-the-competition-head-to-head-review.html

#dailypolitical